Drew Burch

Andrew Burch has extensive leadership experience in the life sciences and financial sectors, currently serving as President of Nucleic Acid Production and EVP of Nucleic Acid Products at Maravai LifeSciences. Previously, Andrew held multiple senior positions at Thermo Fisher Scientific, including President of Softgels, President of Instrument and Enterprise Services, and President of Strategic Initiatives. Andrew also led the Healthcare M&A divisions at Barclays Capital and Lehman Brothers, and served as Managing Director at Merrill Lynch. Academic credentials include a BA in Economics and Political Science (International Relations) from Yale University and an MBA from Stanford University Graduate School of Business.